Research focus
About the research
How can immune cells be re-activated to attack and eradicate tumors?
Read the full research overview
Scott Gerber's laboratory focuses on reversing the process by which tumor cells transform immune cells to elicit tumor-promoting functions. The work uses immunotherapy, described on the page as a new line of cancer treatment, to enhance the body's own immune system to fight cancer. The lab focuses on understanding the complexities of the tumor microenvironment to identify factors that promote tumor growth and to develop therapies that counteract them. One goal of the laboratory is to enhance the efficacy of radiotherapy by targeting and stimulating immune cells.
Selected publications
3 listedToll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer
Journal for ImmunoTherapy of Cancer
Combination of NKG2A and PD-1 Blockade Improves Radiotherapy Response in Radioresistant Tumors
The Journal of Immunology
Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity
International Journal of Molecular Sciences
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings